Down syndrome and postoperative complications after paediatric cardiac surgery: a propensity-matched analysis by Tóth Roland et al.
Down syndrome and postoperative complications after paediatric
cardiac surgery: a propensity-matched analysis
Roland Tótha, Péter Szántób, Zsolt Prodánc, Daniel J Lexa, Erzsébet Sápid, András Szatmárie,
János Gálf, Tamás Szántóg and Andrea Székelyd,f,*
a School of Doctoral Studies, Semmelweis University, Budapest, Hungary
b Gottsegen György Hungarian Institute of Cardiology, Budapest, Hungary
c Department of Pediatric Heart Surgery, Gottsegen György Hungarian Institute of Cardiology, Budapest, Hungary
d Department of Anesthesia and Intensive Care, Gottsegen György Hungarian Institute of Cardiology, Budapest, Hungary
e Department of Pediatric Cardiology, Gottsegen György Hungarian Institute of Cardiology, Budapest, Hungary
f Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary
g Faculty of Information Technology, Pázmány Péter Catholic University, Budapest, Hungary
* Corresponding author. Department of Anesthesia and Intensive Care, Gottsegen György Hungarian Institute of Cardiology, Kútvölgyi út 4, 1125 Budapest, Hungary.
Tel: +36-1-2151220; fax: +36-1-2157096; e-mail: szekelya@kardio.hu (A. Székely).
Received 22 December 2012; received in revised form 2 May 2013; accepted 22 May 2013
Abstract
OBJECTIVES: The incidence of congenital heart disease is 50%, mostly related to endocardial cushion defects. The aim of our study was
to investigate the postoperative complications that occur after paediatric cardiac surgery.
METHODS: Our perioperative data were analysed in paediatric patients with Down syndrome undergoing cardiac surgery. We retrospect-
ively analysed the data from 2063 consecutive paediatric patients between January 2003 and December 2008. After excluding the patients
who died or had missing data, the analysed database (before propensity matching) contained 129 Down patients and 1667 non-Down
patients. After propensity matching, the study population comprised 222 patients and 111 patients had Down syndrome.
RESULTS: Before propensity matching, the occurrences of low output syndrome (21.2 vs 32.6%, P = 0.003), pulmonary complication (14 vs
28.7%, P < 0.001) and severe infection (11.9 vs 22.5%, P = 0.001) were higher in the Down group. Down patients were more likely to
have prolonged mechanical ventilation [median (interquartile range) 22 (9–72) h vs 49 (24–117) h, P = 0.007]. The total intensive care
unit length of stay [6.9 (4.2–12.4) days vs 8.3 (5.3–13.2) days, P = 0.04] and the total hospital length of stay [17.3 (13.3–23.2) days vs
18.3 (15.1–23.6) days, P = 0.05] of the Down patients were also longer. Mortality was similar in the two groups before (3.58 vs 3.88%,
P = 0.86) and after (5.4 vs 4.5%, P = 1.00) propensity matching. After propensity matching, there was no difference in the occurrence of
adverse events.
CONCLUSIONS: After propensity matching Down syndrome was not associated with increased mortality or complication rate following
congenital cardiac surgery.
Keywords: Down syndrome • Paediatrics • Predictors • Paediatric cardiac surgery • Congenital heart disease
INTRODUCTION
Down syndrome (DS) is a genetic disease that is also known as
trisomy of the 21st chromosome and is characterized by various
congenital defects, organic disorders, dysmorphic features and
other health-related problems [1, 2]. This medical condition is
associated with an increased incidence of congenital heart disease
compared with the healthy, genetically normal population [3].
DS patients are most commonly affected by acyanotic heart
lesions. Pulmonary hypertension is a frequent complication of
patients with DS and congenital heart defects that require surgical
treatment [4]. Cardiac surgery is not contraindicated, as previously
suggested, and can be performed with very good results [5].
Previous studies have reported a higher occurrence of post-
operative complications [6].
However, DS patients have decreased buffering of metabolic
derangements and are predisposed to developing leukaemia and
other myeloproliferative disorders [7].
The purpose of this study was to use a propensity-matched ana-
lysis to compare the postoperative morbidity and mortality of
paediatric patients with and without DS who underwent heart
surgery. Our hypothesis was that this chromosomal condition was
associated with increased mortality and morbidity.
METHODS
A total of 2063 consecutive patients (<18 years) undergoing heart
surgery and admitted to our cardiac intensive care unit (ICU)
between January 2003 and December 2008 were screened after
© The Author 2013. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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Institutional Review Board approval (TUKEB 567/2012). The board
waived the need for parental informed consent. After excluding
the cases with missing data (n = 366) and the patients who died
during surgery (n = 27, all were non-Down patients), 1667 patients
(1538 control vs 129 with DS) remained for further analysis (Fig. 1).
We analysed the data from 298 neonates, 570 infants and 799 chil-
dren. The diagnosis of the condition was always based on physical
characteristics and the presence of an extra chromosome 21.
A propensity-matched statistical analysis allowed for the ana-
lysis of patients with similar characteristics. The propensity scores
for DS were estimated using a non-parsimonious multivariable
logistic regression model with 14 baseline covariates according to
our earlier investigation (Fig. 2) [8]. The cardiac surgical procedures
were graded by applying the risk adjustment for congenital heart
surgery (RACHS) score [9]. To quantify the amount of cardiac
support, we calculated the modiﬁed inotropic score as described
by Wernovsky: [dopamine (μg/kg/min) + dobutamine (μg/kg/
min) + 100 × epinephrine (μg/kg/min) + 100 × norepinephrine (μg/
kg/min) × 20 ×milrinone (μg/kg/min)]. Mortality was deﬁned as
death from any cause.
The combined endpoint of the study was deﬁned as death
after arrival at the ICU, including the patients who died after
having been transferred to another hospital or after developing
any of the following complications: postoperative low output
syndrome (LOS) (clinical signs: tachycardia, oliguria, cold extrem-
ities or cardiac arrest and an increase in base deﬁcit >4 on two
consecutive blood gas measurements); pulmonary complication,
deﬁned as non-infectious, non-vascular oxygenation problems
(atelectasia, pneumothorax, chylothorax, phrenic paresis); renal
failure, the need for peritoneal dialysis or haemodialysis;
infections, catheter-related and deep sternal wound infection,
positive blood culture or sepsis. Neurological events, such as con-
vulsion without prior history, haemorrhage or infarction demon-
strated on cranial imaging, were also included in the composite
outcome.
In the statistical analysis, for categorical variables, results are
expressed as counts and percentages and means and standard
deviations (SDs) for categorial and continuous variables, respective-
ly. Patients with missing data on baseline covariates and clinical
outcomes were excluded from the sample. Comparisons of the
demographic and perioperative differences between the patients
were based on the χ2-test, Fisher’s exact test and t-tests, as appro-
priate. Because there were differences in the baseline characteris-
tics, the DS and control groups were not comparable with respect
to important covariates. To minimize differences and overcome the
bias resulting from the study design, we constructed a propensity-
score model for having DS or not. The model’s reliability and pre-
dictive ability were measured with the Hosmer–Lemeshow test and
the c-index, respectively. The receiver operating characteristic
curve’s c-index (area under the curve) was 0.8345, and the
Hosmer–Lemeshow C statistic was 11.3 with a P-value of 0.183
(8 degrees of freedom).
We computed the propensity score using a non-parsimonious
multivariable logistic regression model with DS as the dependent
variable and all the risk factors listed in Tables 1 and 2 as predictor
variables. The DS patients were matched to patients without this
genetic disorder with similar propensity scores. We used a 1:1
nearest-neighbour greedy matching without replacement to form
pairs using callipers of width equal to 0.2 of the SD of the logit of
the propensity score [11]. The 111 matched pairs were analysed
for differences in the baseline characteristics and outcomeFigure 1: Study population before and after matching.
Figure 2: Standardized difference values of the 14 baseline covariates. RACHS: risk adjustment for congenital heart surgery; CPB: cardiopulmonary bypass.
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variables. The outcomes and measured covariates were compared
between groups with a paired t-test for continuous variables and
McNemar’s test for the categorical data. To evaluate the success of
balancing the baseline characteristics between the matched
groups, standardized differences were estimated [12]. Across the
14 baseline covariates, the standardized differences were between
−0.1 and 0.1. Figure 2 indicates that the mean and prevalence of
the variables were similar between the two groups and covariates
were appropriately balanced [13].
All tests were two-sided. We considered P < 0.05 signiﬁcant.
Analyses were conducted with Stata SE 12 (Stata, College Station,
TX, USA), the SPSS 16.0 statistical software (SPSS, Inc., Chicago, IL,
USA) and the STATISTICA 8.0 data analysis software system
(StatSoft, Inc., Tulsa, OK, USA).
Table 1: Predictor variables before matching
Control (n = 1538) Down (n = 129) P-value
Median (n) IQR (%) Median (n) IQR (%)
Age (years) (natural logarithm) −0.005 −1.3 to 1.6 −0.5 −0.8 to 0.06 0.54
Intensive care stay 325 21.1 8 6.2 <0.001
Cyanosis 520 33.8 11 8.5 <0.001
Prostaglandin usage 218 14.2 2 1.6 <0.001
Pulmonary hypertension 203 13.2 76 58.9 <0.001
RACHS
1 240 15.6 5 3.9 <0.001
2 710 46.2 59 45.7
3 455 29.6 64 49.6
4 107 7.0 0 0.00
6 26 1.7 1 0.8
Acute surgery 200 13.0 4 3.1 <0.001
Resternotomy 332 21.6 9 7.0 <0.001
Intraoperative aprotinin administration 337 21.9 11 8.5 <0.001
Blood transfusion (ml/kg) 16 0 to 36.4 33.3 20 to 41.7 <0.001
Cardiopulmonary bypass time (min) 67 41 to 115 90 65 to 115 0.03
Cumulative inotropic index 4 0 to 16 11 6 to 21 <0.001
Nitric oxide 107 7.0 14 10.9 0.10
Delayed sternal closure 227 14.8 14 10.9 0.23
The data are presented as number and occurrence (%) or as median and interquartile range (IQR). Significant values are bold faced.
RACHS: risk adjustment for congenital heart surgery.
Table 2: Predictor variables after matching
Control (n = 111) Down (n = 111) P-value
Median (n) IQR (%) Median (n) IQR (%)
Age (years) (natural logarithm) −0.5 −1.1 to 1.2 −0.5 −0.8 to 0.3 0.85
Intensive care stay 8 7.2 8 7.2 1.00
Cyanosis 12 10.8 11 9.9 1.00
Prostaglandin usage 2 1.8 2 1.8 1.00
Pulmonary hypertension 57 51.4 58 52.3 1.00
RACHS
1 11 9.9 5 4.5 1.00
2 54 48.7 59 53.2
3 39 35.1 46 41.4
4 6 5.4 0 0.00
6 1 0.9 1 0.9
Acute surgery 3 2.7 4 3.6 1.00
Resternotomy 8 7.2 9 8.1 1.00
Aprotinin 8 7.2 11 9.9 0.60
Blood transfusion (ml/kg) 27 0 to 44.4 31.3 15.3 to 41.6 0.89
Cardiopulmonary bypass time (min) 72 55 to 117 81 61 to 113 1.00
Cumulative inotropic index 10 0 to 22 10 4 to 19 0.90
Nitric oxide 8 7.2 10 9.0 0.79
Delayed sternal closure 10 9.0 13 11.7 0.53
Data are presented as number and incidence (%) or median and interquartile range (IQR).
RACHS: risk adjustment for congenital heart surgery.
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RESULTS
During the 6-year period, 2060 patients underwent operations;
366 patients (17.8%) had missing values and 27 patients (1.3%)
died intraoperatively. Before propensity matching in the study
population of 1667 patients, 129 patients (7.74%) had DS. After
propensity matching, we had 222 patients in the study population
and 111 (50.0%) had DS.
The propensity score matching yielded 111 pairs of patients in
our unbiased database. There were no differences in the baseline
characteristics between the pairs in our balanced system. The
standardized difference was used to assess the balance of the cov-
ariates because it did not depend on the size of the sample. A
standardized difference of less than the absolute value of 10% was
used to indicate that the preoperative and perioperative charac-
teristics across groups were comparable. The mean propensity
score of the Down and the control groups were 0.210 and 0.220,
respectively.
Before propensity matching, the patients with DS had higher
morbidity values; however, there were no signiﬁcant differences
between the non-Down and Down groups with regard to mortal-
ity before and after propensity matching [before, n = 55 (3.58%) vs
5 (3.88%); after, n = 6 (5.41%) vs 5 (4.5%)] (Tables 3 and 4). Further
demographic and perioperative characteristics before and after
matching are presented in Tables 1 and 2.
Signiﬁcant differences were detectable before propensity
matching between the Down and non-Down groups regarding
nearly all of the predictor variables. More children were admitted
preoperatively to the ICU in the non-Down group and they were
more likely to have preoperative cyanosis or needed prostaglan-
din before the operation. We found more patients with preopera-
tive pulmonary hypertension in the Down group. Non-Down
patients needed acute surgery more frequently than the children
with DS. A greater amount of aprotinin was given to the
non-Down patients intraoperatively. Down patients required
more blood transfusions, had longer cardiopulmonary bypass
times and received higher amounts of inotropic drugs than those
without the disorder. Down children had mostly primary opera-
tions. Patients with DS underwent less complex surgeries accord-
ing to their RACHS points (Table 1). Before matching, the
occurrence of cyanotic heart disease was lower in patient with DS
[15 (11.6%) vs 364 (23.6%), P = 0.002, in Down vs non-Down
patients, respectively]. In the matched population, the occurrence
of cyanotic disease was similar (P = 0.88). There were no signiﬁcant
Table 3: Outcome variables before matching
Control (n = 1538) Down (n = 129) P-value
Median (n) IQR (%) Median (n) IQR (%)
Combined outcome 246 16.0 34 26.4 0.002
Death 55 3.6 5 3.9 0.86
Low output syndrome 326 21.2 42 32.6 0.003
Mechanical ventilation (h) 22 9–72 49 24–117 0.007
Pulmonary complication 215 14.0 37 28.7 <0.001
Renal failure 88 5.7 9 7.0 0.56
Severe infection 183 11.9 29 22.5 0.001
Neurological event 35 2.3 0 0.00 0.08
ICU stay (days) 6.9 4.2–12.4 8.3 5.3–13.2 0.04
Hospital stay (days) 17.3 13.3–23.2 18.3 15.1–23.6 0.05
Data are presented as number and incidence (%) or median and inter-quartile range (IQR). Significant values are bold faced.
ICU: intensive care unit.
Table 4: Outcome variables after matching
Control (n = 111) Down (n = 111) P-value
Median (n) IQR (%) Median (n) IQR (%)
Combined outcome 25 22.5 27 24.3 0.76
Death 6 5.4 5 4.5 1.00
Low output syndrome 32 28.9 35 31.5 0.67
Mechanical ventilation (h) 32 11–75 46 23–114 0.12
Pulmonary complication 23 20.7 31 27.9 0.22
Renal failure 5 4.5 6 5.4 1.00
Severe infection 20 18.0 22 19.8 0.74
Neurological event 3 2.7 0 0.0 0.25
ICU stay (days) 7.2 4.4–11 8.2 5.3–12.9 0.15
Hospital stay (days) 17.5 14.2–23.7 18.1 14.3–23.3 0.27
Data are presented as number and incidence (%) or median and inter-quartile range (IQR).
ICU: intensive care unit.
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differences in the postoperative mortality and composite mortal-
ity. Table 2 shows that after propensity matching of the above-
mentioned predictive values, the differences disappeared. We
could not determine any signiﬁcant variance in our statistically
balanced system. According to our data (after matching), in the
postoperative period, 48 patients (46%) with DS received thyroxin
through the nasogastric tube, while only 29 patients (26%) of the
control group (P = 0.008) received the medication. Additionally,
only 8 patients (7%) received insulin infusion compared with
20 patients (18%) in the control group (P = 0.018). Steroid adminis-
tration was similar in the two groups (P = 0.99).
Tables 3 and 4 present the outcomes of the patients before and
after propensity matching. Before propensity matching, the Down
patients had higher mortality and morbidity rates than the
non-Down patients. The occurrence of LOS, pulmonary complica-
tion, renal failure and severe infection was higher in the Down
group. Down patients were also more likely to undergo prolonged
mechanical ventilation. The incidence of neurological events was
higher in the non-Down group but the variation was not signiﬁ-
cant. The lengths of the ICU and hospital stays were also longer in
the Down group than in the case of control patients. After propen-
sity matching, there was no signiﬁcant variation detectable
between the Down and control groups (Table 4).
Table 5 shows the measured perioperative laboratory values
of both groups (control and DS) after propensity matching. The
haemoglobin levels in the Down group were higher in the post-
operative period. The platelet counts were lower in the DS
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Table 6: Procedures by patient group after matching
Procedure Down Control P-value
ASD repair, patch 2 5 0.44
AVSD repair, intermediate (transitional) 7 0 0.01
AVSD repair, partial (incomplete) 7 0 0.01
AVSD repair, complete 30 19 0.07
Coarctation repair, end-to-end 3 4 1
DORV, intraventricular tunnel repair 1 7 0.06
Norwood procedure 1 0 1
PA banding 3 4 1
PDA closure, surgical 3 3 1
RVOT procedure 1 2 1
Shunt, systemic-to-pulmonary, MBTS 3 2 1
TOF repair 6 6 1
Valve replacement, mitral 2 1 1
Valvuloplasty, mitral 7 5 0.55
Valvuloplasty, tricuspid 5 0 0.06
VSD repair, patch 30 31 0.88
Aortic root repair 0 1 1
DKS 0 1 1
Double chamber 0 1 1
Fontan. 0 4 0.12
PAPVC 0 3 0.24
Ross 0 7 0.01
TAC 0 2 0.49
TAPVC 0 3 0.24
ASD: atrial septal defect; AVSD: atrioventricular septal defect; DORV:
double outlet right ventricle; PA: pulmonary artery; PDA: persistent
ductus arteriosus; RVOT: right ventricle outflow tract; MBTS: modified
Blalock–Taussig shunt; TOF: tetralogy of Fallot; VSD: ventricular septal
defect; DKS: Damus–Kaye–Stansel procedure; PAPVC: partial
anomalous pulmonary venous connection; TAC: transverse aortic
constriction; TAPVC: total anomalous pulmonary venous connection.
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patients. Creatinine clearance was lower in the Down patients
during the entire perioperative period.
Table 6 shows the procedures by the two groups after propen-
sity matching. The only differences observable were in the cases
when no match was found, namely when transitional and partial
atrioventricular septal defect (AVSD) repair, tricuspid valvuloplasty
and Ross procedure were performed.
DISCUSSION
We found that patients with DS had higher occurrences of post-
operative complications. Using propensity score methods, we
matched a large number of patients who had DS in a paediatric
cardiac surgical population to a group of patients (comparable
with respect to every measured covariate) who did not suffer from
this disorder. After the propensity matching, there were no signiﬁ-
cant differences in postoperative complications and mortality
between the Down and non-Down patients. More patients with
DS were treated with thyroxin in the postoperative period. We
found lower levels of platelets and creatinine clearance in the
patients with DS.
The cumulative mortality of patients with DS after cardiac
surgery was comparable or even lower than in the patients with
normal karyotypes after congenital heart surgery [14]. If open
heart surgery was performed, a prolonged cardiopulmonary
bypass time was associated with a higher mortality risk [15]. Many
things depend also on the right timing of surgery, which is some-
times different in Down and non-Down patients. For instance, the
repair of AV canal within 4 months of age leads to fewer complica-
tions in patients with DS compared with others (where the
achievement of competent valves is more difﬁcult to obtain). The
mortality data were adjusted in our analysis, but the occurrence of
prolonged cardiopulmonary bypass time was more likely in the
patients with DS before matching.
Another point to be considered in children with DS is that they
frequently have LOS, which adversely affects surgical outcomes
[16]. Indeed, these differences could also be detected in our study
population; the patients with DS had higher rates of low cardiac
output syndrome and pulmonary complications. However, our
results indicated that these adverse events may be caused by the
degree of the operation complexity and the intraoperative vari-
ables, such as inotropic dose or the amount of transfusion. After
adjusting for the intraoperative variables, the occurrence of post-
operative complications was similar in the Down and control
groups. In accordance with our ﬁndings, pain relief and the dur-
ation of mechanical ventilation did not differ in the patients with
DS vs the controls [17].
The occurrence of postoperative renal failure requiring dialysis
(haemodialysis or peritoneal dialysis) was similar in both groups,
despite the lower pre- and postoperative creatinine clearance in
the DS patients. Previous reports have not suggested frequent
renal dysfunction in patients with DS [18]. The lower creatinine
clearance in our study population might have been caused by
cardio-renal syndrome or previous anticongestive medications
[19]. The patients with DS spent signiﬁcantly more time in the ICU
and stayed signiﬁcantly longer in the hospital, but this variance
also disappeared after propensity matching. Other studies have
also demonstrated prolonged hospital stays with Down patient
hospitalized in general ICUs. [2].
The incidence of infective complications was frequent in the
Down group. This observation is in agreement with the results of
other studies [20]. Children with DS are at high risk of thyroid
dysfunction; subclinical hypothyroidism is the most common
thyroid abnormality in these patients. Frequent infections are
presumably caused by impaired immune responses, and the inci-
dence of autoimmunity, including hypothyroidism, is increased
[21]. In our study population, DS patients were more frequently
treated with thyroxin. This difference might explain why the oc-
currence of infections was comparable with the propensity-
matched control population. The decreased buffering of metabol-
ic processes results in increased insulin resistance. Therefore,
diabetes mellitus develops in many affected patients [22]. In our
paediatric patients, we observed a tendency towards lower base
excess, but it did not reach signiﬁcance.
Isolated thrombocytopenia, thrombocytosis and several other
haematological disorders can be observed in DS patients [23]. In
the unmatched cohort, the need for intraoperative blood transfu-
sions was signiﬁcantly higher in DS patients. In our population, the
postoperative haemoglobin levels were signiﬁcantly higher and
the platelet count was signiﬁcant lower in the Down patients after
propensity matching. Because we matched the patients according
to their pre- and intraoperative variables, we could not compare
the need for intraoperative transfusion. Our previous study did not
ﬁnd an independent relationship between DS and transfusion [24].
Our study had limitations. The retrospective analysis did not
allow of an investigation into causes and consequences. However,
our proprietary hospital database recorded prospective clinical,
diagnostic and outcome data on all the paediatric ICU patients
since January 2003. This was a single-centre study and the database
comprised patients of different ages with heterogeneous congenital
heart defects, which improves the generalizability of the study. Our
analysis applied propensity score matching, which can balance bias
based on heterogeneity of patient and operation characteristics.
In conclusion, we found that after propensity matching, the
perioperative values we studied did not inﬂuence the outcomes of
DS patients and there were no signiﬁcant differences between the
Down and non-Down groups with regard to the rates of post-
operative complications or mortality after matching. This statistical
method, which used similar values for the variables, can play an
important role in identifying the differences between control and
investigated groups.
Conﬂict of interest: none declared.
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